# UPMC Hillman Cancer Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/upmc-hillman-cancer-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 76 |
| Citations | 3,103,572 |
| City | Pittsburgh |
| Country | US |
| Description | UPMC Hillman Cancer Center is a research organisation in Pittsburgh, US. OpenAlex records 17,181 works and 3,103,572 citations for it. 2,909 researchers list it as their most recent affiliation. |
| Homepage | https://hillmanresearch.upmc.edu |
| OpenAlex ID | https://openalex.org/I4210128526 |
| Researchers | 2,909 |
| ROR ID | https://ror.org/03bw34a45 |
| Type | facility |
| Works | 17,181 |

## University collaborators

- [Sidney Kimmel Comprehensive Cancer Center](https://scholariq.org/institutions/sidney-kimmel-comprehensive-cancer-center/)
- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

## University papers

Showing 12 of 34.

- [Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration](https://scholariq.org/papers/strengthening-the-reporting-of-observational-studies-in-epidemiology-strobe/)
- [Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden](https://scholariq.org/papers/analysis-of-100-000-human-cancer-genomes-reveals-the-landscape-of-tumor/)
- [Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes](https://scholariq.org/papers/cancer-regression-in-patients-after-transfer-of-genetically-engineered/)
- [Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma](https://scholariq.org/papers/identification-of-a-cpg-island-methylator-phenotype-that-defines-a-distinct/)
- [Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy](https://scholariq.org/papers/durable-complete-responses-in-heavily-pretreated-patients-with-metastatic/)
- [5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers](https://scholariq.org/papers/5-cpg-island-methylation-is-associated-with-transcriptional-silencing-of-the/)
- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma](https://scholariq.org/papers/adoptive-cell-transfer-therapy-following-non-myeloablative-but-lymphodepleting/)
- [Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1](https://scholariq.org/papers/tumor-regression-in-patients-with-metastatic-synovial-cell-sarcoma-and-melanoma/)
- [Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.](https://scholariq.org/papers/inactivation-of-the-cdkn2-p16-mts1-gene-is-frequently-associated-with-aberrant/)
- [Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer](https://scholariq.org/papers/dysfunctional-keap1-nrf2-interaction-in-non-small-cell-lung-cancer/)
- [Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.](https://scholariq.org/papers/detection-of-aberrant-promoter-hypermethylation-of-tumor-suppressor-genes-in/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.